Venom variation in hemostasis of the southern Pacific rattlesnake (Crotalus oreganus helleri): Isolation of hellerase

Comparative Biochemistry and Physiology - C Toxicology and Pharmacology

Volumn 149, Issue 3, 2009, Pages 307-316

  Salazar, Ana Maria ^a   Guerrero, Belsy ^a   Cantu, Bruno ^b   Cantu, Esteban ^b   Rodríguez Acosta, Alexis ^c   Pérez, John C ^b   Galán, Jacob A ^d,e   Tao, Andy ^d,e   Sánchez, Elda E ^b  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b TEXAS A AND M UNIVERSITY KINGSVILLE   (United States)

^c UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^d PURDUE UNIVERSITY   (United States)

^e PURDUE UNIVERSITY   (United States)

Author keywords

Crotalus oreganus helleri; Fibrinolytic activity; Hemostasis; Platelet aggregation; Southern Pacific rattlesnakes; Venom variation

Indexed keywords

FIBRIN; HELLERASE; METALLOPROTEINASE; SNAKE VENOM; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BLEEDING; CHEMICAL ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CROTALUS OREGANUS HELLERI; ENZYME ACTIVITY; FIBRINOLYSIS; FRACTIONATION; GEOGRAPHICAL VARIATION (SPECIES); HEMOSTASIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SNAKE; UNITED STATES;

CROTALUS OREGANUS HELLERI;

EID: 60649105308     PISSN: 15320456     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpc.2008.08.007     Document Type: Article

References (65)

1. Aguilar I., Guerrero B., Salazar A.M., Girón M.E., Pérez J.C., Sánchez E.E., and Rodríguez-Acosta A. Individual venom variability in the South American rattlesnake Crotalus durissus cumanensis. Toxicon 50 (2007) 214-224
2. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W., and Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic. Acids. Res. 25 (1997) 3389-3402
3. Austen D., and Rhymes I. A Laboratory Manual of Blood Coagulation (1975), Blackwell Scientific Publications, Oxford
4. Bajwa S., Markland F.S., and Russell F.E. Fibrinolytic and fibrinogen clotting enzymes present in the venoms of western diamondback rattlesnake, Crotalus atrox, eastern diamondback rattlesnake, Crotalus adamanteus, and southern Pacific rattlesnake, Crotalus viridis helleri. Toxicon 19 (1981) 53-59
5. Bello C., Hermogenes A.L., Magalhaes A., Veiga S.S., Gremski L.H., Richardson M., and Sanchez E.F. Isolation and biochemical characterization of a fibrinolytic proteinase from Bothrops leucurus-tailed jararaca) snake venom. Biochimie 88 (2006) 189-200
6. Bjarnason J., and Fox J.W. Hemorrhagic metalloproteases from snake venoms. Pharmacol. Ther. 62 (1994) 325-372
7. Bjarnason J., and Tu A.T. Hemorrhagic toxins from western diamondback rattlesnake (Crotalus atrox) venom: isolation and characterization of five toxins and the role of zinc in hemorrhagic toxin e. Biochemistry 17 (1978) 3395-3404
8. Bock P., Panizzi P., and Verhamme I.M. Exosites in the substrate specificity of blood coagulation reactions. J. Thromb. Haemost. 5 Suppl 1 (2007) 81-94
9. Brooks D., Graeme K.A., Ruha A.M., and Tanen D.A. Respiratory compromise in patients with rattlesnake envenomation. J. Emerg. Med. 23 (2002) 329-332
10. Chang C., and Tseng K.H. Effect of crotamine, a toxin of South American rattlesnake venom, on the sodium channel of murine skeletal muscle. Brit. J. Pharmacol. 63 (1978) 551-559
11. Chen T., and Rael E.D. Purification of M5, a fibrinolytic proteinase from Crotalus molossus molossus venom that attacks complement. Int. J. Biochem. Cell Biol. 29 (1997) 789-799
12. Cheymol J., Gonçalves J.M., Bourillet F., and Roch-Arveiller M. Action neuromusculaire comparée de la crotamine et du venin de Crotalus durissus terrificus var crotaminus./I./sur préparations neuromusculaire in situ. Toxicon 9 (1971) 279-286
13. Chippaux J., Williams V., and White J. Snake venom variability: methods of study, results and interpretation. Toxicon 29 (1991) 1279-1303
14. Condrea E., and De Vries A. Hemolysis and splitting of human erythrocyte phospholipids by snake venoms. Biochim. Biophys. Acta. 84 (1964) 60-73
15. Dempfle C., Argiriou S., Kucher K., Müller-Peltzer H., Rübsamen K., and Heene D.L. Analysis of fibrin formation and proteolysis during intravenous administration of ancord. Blood 96 (2000) 2793-2802
16. Didisheim P., and Lewis J.H. Fibrinolytic and coagulant activities of certain snake venoms and proteases. Proc. Soc. Exp. Biol. Med. 93 (1956) 10-13
17. D'Suze G., Corona F., Possani L.D., and Sevcik C. HPLC purification and amino acid sequence of toxins from the muscarinic fraction of Tityus discrepans scorpion venom. Toxicon 34 (1996) 591-598
18. Estevao-Costa M., Diniz C.R., Magalhaes A., Markland F.S., and Sanchez E.F. Action of metalloproteases mutalysis I and II on several components of the hemostatic and fibrinolytic systems. Thromb. Res. 99 (2000) 363-376
19. Fox J.W., and Bjarnason J.B. Metalloproteinase inhibitors. In: Bailey G.S. (Ed). Enzymes from Snake Venoms (1998), Alaken Inc, Fort Collins, CO 599-632
20. French W., Hayes W.K., Bush S.P., Cardwell M.D., Bader J.O., and Rael E.D. Mojave toxin in venom of Crotalus helleri (Southern Pacific Rattlesnake): molecular and geographic characterization. Toxicon 44 (2004) 781-791
21. Friberger P. Chromogenic peptide substrates. Their use for the assay of factors in the fibrinolytic and the plasma kallikrein-kinin systems. Scand. J. Clin. Lab. Invest. Suppl. 162 (1982) 1-298
22. Glenn J., Straight R.C., Wolfe M.C., and Hardy D.L. Geographical variation in Crotalus scutulatus scutulatus (Mojave rattlesnake) venom properties. Toxicon 21 (1983) 119-130
23. Gold B., Barish R.A., Dart R.C., and Barish R.A. Bites of venomous snakes. New Engl. J. Med. 347 (2002) 347-356
24. Gonçalves J. Estudos sobre venenos de serpents brasileiras. II-Crotalus terrificus crotaminicus, subespécie biológica. An. Acad. Bras. Cienc. 28 (1956) 365-367
25. Guan A., Retzios A.D., Henderson G.N., and Markland Jr. F.S. Purification and characterization of a fibrinolytic enzyme from venom of the southern copperhead snake (Agkistrodon contortrix contortrix). Arch. Biochem. Biophys. 289 (1991) 197-207
26. Guerrero B., and Arocha-Piñango C.L. Activation of human prothrombin by the venom of Lonomia achelous (Cramer) caterpillars. Thromb. Res. 66 (1992) 169-177
27. Gutiérrez J.M., Rucavado A., Escalante T., and Díaz C. Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage. Toxicon 45 (2005) 997-1011
28. Habermann E., and Hardt K.L. A sensitive and specific plate test for the quantitation of phospholipases. Anal. Biochem. 50 (1972) 163-173
29. Johnston M., Fativich D.M., Haig A.D., and Dalys F.F.S. Successful resuscitation after cardiac arrest following massive brown snake envenomation. Med. J. Aust. 177 (2002) 646-649
30. Jurado J., Rael E.D., Lieb C.S., Nakayasu E., Hayes W.K., Bush S.P., and Ross J.A. Complement inactivating proteins and intraspecies venom variation in Crotalus oreganus helleri. Toxicon 49 (2007) 339-350
31. Klauber, L.R., 1956. Their Habits, Life Histories, and Influence on Mankind. University of California Press, Berkeley. Rattlesnakes, Their Habits, Life Histories, and Influence on Mankind. Berkeley: University of California Press.
32. Komori Y., Hagihara S., and Tu A.T. Specificity of hemorrhagic proteinase from Crotalus atrox (western diamondback rattlesnake) venom. Biochim. Biophys. Acta 829 (1985) 127-130
33. Langely R. Animal bites and stings reported by United States Poison Control Centers, 2001-2005. Wilderness Environ. Med. 19 (2008) 7-14
34. Mackessy S. Venom ontogeny in the Pacific Rattlesnakes Crotalus viridis helleri and C. v. oreganus. Copeia 1988 (1988) 92-101
35. Mackessy S. Venom Composition in Rattlesnakes: Trends and Biological Significance (2008), Loma Linda University Press, Loma Linda
36. Maeda N., Tamiya N., Pattabhiraman T.R., and Russell F.E. Some chemical properties of the venom of the rattlesnake, Crotalus viridis helleri. Toxicon 16 (1979) 431-441
37. Markland F.J. Inventory of alpha- and beta- fibrinogenases from snake venom. For the subcommittee on nomenclature of exogenous hemostatic factor of the scientific and standardization committee of the international society on thrombosis and hemostasis. Thromb. Haemost. 65 (1991) 438-443
38. Markland F. Snake venom and the hemostatic system. Toxicon 36 (1998) 1749-1800
39. Marsh N., and Arocha-Piñango C.L. Evaluation of the fibrin plate method for estimating plasminogen activators. Thromb. Diath. Haemorrh. 28 (1972) 75-88
40. Matsui T., Fujimura Y., and Titani K. Snake venom proteases affecting hemostasis and thrombosis. Biochim. Biophys. Acta 1477 (2000) 146-156
41. MERCK & CO. I. 1998. AGGRASTAT® (Tirofiban hydrochloride injection premixed), AGGRASTAT® (Tirofiban hydrochloride injection). 9123301.
42. Moll S., Kenyon P., Bertoli L., De Maio J., Homesley H., and Deitcher S.R. Phase II trial of alfimeprase, a novel-acting fibrin degradation agent, for occluded central venous access devices. J. Clin. Oncol. 24 (2006) 3056-3060
43. Mori N., Nikai T., Sugihara H., and Tu A.T. Biochemical characterization of hemorrhagic toxins with fibrinogenase activity isolated from Crotalus ruber ruber venom. Arch. Biochem. Biophys. 253 (1987) 108-121
44. Omori-Satoh T., Sadahiro S., Ohsaka A., and Murata R. Purification and characterization of an antihemorrhagic factor in the serum of Trimeresurus flavoviridis, a crotalid. Biochim. Biophys. Acta 285 (1972) 414-426
45. Petersen L.C., Boel E., Johannessen M., and Foster D. Quenching of the amidolytic activity of one-chain tissue-type plasminogen activator by mutation of lysine-416. Biochemistry 29 (1990) 3451-3457
46. Pućkowska A., Midura-Nowaczek K., and Bruzgo I. Effects of netropsin and pentamidine amino analogues on the amidolytic activity of plasmin, trypsin and urokinase. Acta Pol. Pharm. 65 (2008) 213-215
47. Ribeiro L., Puorto G., and Jorge M.T. Bites by the colubrid snakes Philodryas olfersii: a clinical and epidemiological study of 43 cases. Toxicon 37 (1999) 943-948
48. Rodrigues V., Soares A.M., Guerra-Sa R., Rodrigues V., Fontes M.R., and Giglio J.R. Structural and functional characterization of neuwiedase, a nonhemorrhagic fibrino(geno)lytic metalloproteinase from Bothrops neuwiedi snake venom. Arch. Biochem. Biophys. 381 (2000) 213-224
49. Rodríguez-Acosta A., Lemoine K., Navarrete L.F., Girón M.E., and Aguilar I. Experimental ophitoxemia produced by the opisthoglyphous Lora snake (Philodryas olfersii) (Serpentes: Colubridae) venom. Rev. Soc. Bras. Med. Trop. 39 (2006) 193-197
50. Rudolph R., Neal G.E., Williams J.S., and McMahan A.P. Snakebite treatment at a Southeastern regional referral center. Am. Surg. 61 (1995) 767-772
51. Salazar A., Rodríguez-Acosta A., Girón M.E., Aguilar I., and Guerrero B. A comparative analysis of the clotting and fibrinolytic activities of the mapanare (Bothrops atrox) snake venom from different geographical areas in Venezuela. Thromb. Res. 120 (2007) 95-104
52. Salazar A.M., Aguilar I., Guerrero B., Gir, ó n M.E., Lucena S., Sanchez E.E., and Rodríguez -Acosta A. Intraspecies differences in hemostatic venom activities of the South American rattlesnakes, Crotalus durissus cumanensis, as revealed by a range of protease inhibitors. Blood Coagul. Fibrinolysis 19 (2008) 525-530
53. Salvesen G., and Nagase H. Inhibition of proteolytic enzymes. In: Beynon R.J., and Bond J.S. (Eds). Proteolytic Enzymes: A Practical Approach (1989), IRL Press, London 83-104
54. Sánchez E.E., Galán J.A., Powell R.L., Reyes S.R., Soto J.G., Russell W.K., Russell D.H., and Pérez J.C. Disintegrin, hemorrhagic, and proteolytic activities of Mohave rattlesnake, Crotalus scutulatus scutulatus venoms lacking Mojave toxin. Comp. Biochem. Physiol. C 141 (2005) 124-132
55. Schägger H., and von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166 (1987) 368-379
56. Sharma M., and Sharma M. The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target. Curr. Pharm. Des. 13 (2007) 3568-3575
57. Spearman-Karber R. Alternative Methods of Analysis for Quantal Responses (1978), Charles Griffin, London
58. Stocker K. Snake Venom Proteins Affecting Hemostasis and Fibrinolysis (1990), CRC Press, Boca Raton
59. Swenson S., and Markland Jr. F.S. Snake venom fibrin(ogen)olytic enzymes. Toxicon 45 (2005) 1021-1039
60. Takeya H., Onikura A., Nikai T., Sugihara H., and Iwanaga S. Primary structure of a hemorrhagic metalloproteinase, HT-2, isolated from the venom of Crotalus ruber ruber. J. Biochem. 108 (1990) 711-719
61. Toombs C. Alfimeprase: pharmacology of a novel fibrinolytic metalloproteinase for thrombolysis. Hemostasis 31 (2001) 141-147
62. Toombs C. New directions in thrombolytic therapy. Curr. Opin. Pharmacol. 1 (2001) 164-168
63. Verma R., and Hansch C. Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. Bioorg. Med. Chem. 15 (2007) 2223-2268
64. White J. Snake venoms and coagulopathy. Toxicon 45 (2005) 951-967
65. Willis T., and Tu A.T. Purification and biochemical characterization of atroxase, a nonhemorrhagic fibrinolytic protease from western diamondback rattlesnake venom. Biochemistry 27 (1988) 4769-4777